Gender-Specific High-Risk 'Window' Seen in Alzheimer's

Share this content:
Gender-Specific High-Risk 'Window' Seen in Alzheimer's
Gender-Specific High-Risk 'Window' Seen in Alzheimer's

TUESDAY, Aug. 29, 2017 (HealthDay News) -- Women with a genetic predisposition for Alzheimer's disease face a 10-year window -- between ages 65 and 75 -- when they have far greater chances of developing the disease than men with similar genetic risks, according to a study published online Aug. 28 in JAMA Neurology.

The analysis included 31,340 white North Americans and Europeans in the Global Alzheimer's Association Interactive Network. All were diagnosed with Alzheimer's between the ages of 55 and 85. The researchers focused on carriers of the apolipoprotein E ε4 allele.

The investigators found that genetically vulnerable white men and white women aged 55 to 85 have similar odds for developing the disease except during the time between the ages 65 and 75, when the risk appears to increase for women.

"Menopause and plummeting estrogen levels, which on average begins at 51, may account for the difference," study coauthor Judy Pa, Ph.D., an assistant professor of neurology at the University of Southern California's Neuroimaging and Informatics Institute in Los Angeles, said in a university news release. The researchers added larger and diverse studies that involve more women and minorities are needed to confirm their findings.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »